Researcher
Guido Vanham
Affiliations
- Virology (Research unit)
Member
From1 Jan 1989 → 30 Jul 2019
Projects
1 - 10 of 19
- Machine learning framework for T-cell receptor repertoire-based viral diagnosticsFrom3 Nov 2020 → Today
- Evaluation of the role of immune checkpoint molecules in the natural killer cell-mediated anti-HIV responseFrom11 Apr 2019 → Today
- Development of a novel nanoparticle formulation for mRNA based therapeutic vaccination against HIVFrom11 Apr 2019 → Today
- Immuno Cytometry: Phenotyping immune cellular components, in the context of HBV, HIV and AD, by new, advanced technologiesFrom18 Jan 2018 → 17 Aug 2020
- Interventions towards a functional cure: detailed phenotyping of the HIV-specific polyfunctional CD8+ T cell responses of controllersFrom24 Jun 2016 → 12 Feb 2020
- Search for host genetic factors associated with neurological complications (HAM/TSP) in Peruvian HTLV-1 infected individualsFrom18 May 2016 → 27 Sep 2016
- Rationeel ontwerp van een therapeutisch vaccin tegen HIV-1 gebaseerd op een nieuwe formulering van nanopartikelFrom1 Jan 2016 → 31 Dec 2020
- Cell-associated HIV-RNA as a superior marker of treatment success or failureFrom29 Apr 2015 → 19 Sep 2019
- Therapeutic TriMix/Mrna BASED Vaccine in Chronic HIV-1 Infected Patients Receiving Antiretroviral TherapyFrom1 Dec 2013 → 31 Dec 2017
- Inductie van breed-potente Hiv-1 suppressieve immuun responsen door dendritische cellen opgeladen met gag mRNA.From1 Jan 2011 → 21 Mar 2019
Publications
21 - 30 of 206
- Immunomodulatory therapy of visceral leishmaniasis in human immunodeficiency virus-coinfected patients(2018)
Authors: Wim Adriaensen, Thomas P C Dorlo, G Vanham, Luc Kestens, Paul M Kaye, J van Griensven
- Pharmacodynamic activity of DS003, a novel gp120 blocker, when administered to women as a vaginal tablet(2018)
Authors: Jeremy Nuttall, Kevin Ariën, J Michiels, Meryam Krit, G Vanham, Pascal van Tilburg, Leonie du Puy, Neliette van Niekerk, Annalene Nel
Pages: 341-341 - Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection(2018)
Authors: Lorna Leal, Alberto C. Guardo, Sara Moron-Lopez, Maria Salgado, Beatriz Mothe, Carlo Heirman, Pieter Pannus, G Vanham, Henk-Jan van den Ham, Rob Gruters, et al.
Pages: 2533-2545 - Visualization of X4-and R5-tropic HIV-1 viruses expressing fluorescent proteins in human endometrial cells: application to tropism study(2017)
Authors: Rachel Terrasse, Meriam Memmi, Sabine Palle, L Heyndrickx, G Vanham, Bruno Pozzetto, Thomas Bourlet
- A longitudinal analysis of the vaginal microbiota and vaginal immune mediators in women from sub-Saharan Africa(2017)
Authors: Vicky Jespers, J.K. Kyongo, Sarah Joseph, Liselotte Hardy, Piet Cools, Tania Crucitti, Mary Mwaura, Gilles Ndayisaba, Sinead Delany-Moretlwe, Jozefien Buyze, et al.
- Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in Europe(2017)
Authors: Francois Blanquart, Chris Wymant, Marion Cornelissen, Astrid Gall, Margreet Bakker, Daniela Bezemer, Matthew Hall, Mariska Hillebregt, Swee Hoe Ong, Jan Albert, et al.
- Type I interferons interfere with the capacity of mRNA lipoplex vaccines to elicit cytolytic T cell responses(2016)
Authors: Ans De Beuckelaer, C Pollard, Sandra Van Lint, Kenny Roose, Lien Van Hoecke, Thomas Naessens, Vimal Kumar Udhayakumar, Muriel Smet, Niek Sanders, Stefan Lienenklaus, et al.
Pages: 2012-2020 - Evolutionary dynamics and complicated genetic transmission network patterns of HIV-1 CRF01_AE among MSM in Shanghai, China(2016)
Authors: Xiaoshan Li, Yile Xue, Yi Lin, Jing Gai, Lei Zhang, Hua Cheng, Zhen Ning, Leiming Zhou, Kexin Zhu, G Vanham, et al.
- CD4-mimetic sulfopeptide conjugates display sub-nanomolar anti-HIV-1 activity and protect macaques against a SHIV162P3 vaginal challenge(2016)
Authors: Kevin Ariën, Françoise Baleux, Delphine Desjardins, Françoise Porrot, Yves-Marie Coïc, J Michiels, Kawthar Bouchemal, David Bonnaffé, Timothée Bruel, Olivier Schwartz, et al.
- Resistance and cross-resistance profile of the diaryltriazine NNRTI and candidate microbicide UAMC01398(2016)
Authors: Kevin Ariën, Muthusamy Venkatraj, J Michiels, Jurgen Joossens, K Vereecken, Pieter Van der Veken, Jan Heeres, Hans De Winter, L Heyndrickx, Koen Augustyns, et al.
Pages: 1159-1168